MENU
XERS
AS OF
Nov 13 closing price
Price
$7.26
Change
-$0.33 (-4.35%)
Capitalization
1.2B
117 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
XERS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Xeris Biopharma Holdings (XERS) Earnings Date & Reports

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States... Show more

A.I. Advisor
published Earnings

XERS is expected to report earnings to rise ∞% to 3 cents per share on March 11

Xeris Biopharma Holdings XERS Stock Earnings Reports
Q4'25
Est.
$0.04
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.03
The last earnings report on November 06 showed earnings per share of 0 cents, missing the estimate of 0 cents. With 2.74M shares outstanding, the current market capitalization sits at 1.20B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
XERS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. XERS showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for XERS
A.I. Advisor
published General Information

General Information

a developer of ready-to-use, liquid-stable injectables

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1375 West Fulton Street
Phone
+1 844 445-5704
Employees
377
Web
https://www.xerispharma.com